Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
Find a Physician
News and Updates
Ways to Give
Neurology
Explore this Website
I am interested in...
Wayfinder menu
Find a Physician
News and Updates
Ways to Give
Home
About Us
Toggle About Us menu options
Leadership Directory
News and Updates
Events
Affiliated Institutions
Speakers Bureau
Videos
Contact Us
Ways to Give
Patient Care
Education
Toggle Education menu options
Medical School Neurology Curriculum
Residency
Toggle Residency menu options
Residency Education Leadership
Our Residents
Program Highlights
Resident Research and Educator Track
Resident Publications
Where Are Our Residents Now?
Rotation Sites
Teaching Program
Rotations Schedule
Neurology Subspecialties
New York City
Housing and Stipends
Apply to Residency Program
Fellowship Training
Toggle Fellowship Training menu options
Clinical Neurophysiology Fellowship
Epilepsy Fellowship
Neurocritical Care Fellowship
Vascular Neurology Fellowship
Neurooncology Fellowship
Headache Fellowship
Multiple Sclerosis Fellowship
Grand Rounds
Continuing Medical Education
Educator Development
Education Scholarship
Research
Toggle Research menu options
Clinical Trials
Publications
Women's Brain Initiative
Brain and Nerve Stimulation Program
Diversity and Community Outreach
Toggle Diversity and Community Outreach menu options
Diversity
Community Outreach
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Patient Care
Education
Research
Diversity and Community Outreach
Home
Biblio
Found 12 results
Filters:
Author
is
Perumal, Jai S
[Clear All Filters]
2022
Marcille M
,
RĂșa SHurtado
,
Tyshkov C
,
Jaywant A
,
Comunale J
,
Kaunzner UW
,
Nealon N
,
Perumal JS
,
Zexter L
,
Zinger N
et al.
. 2022.
Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.
.
Sci Rep. 12(1):4411.
2018
Ranganathan U
,
Kaunzner U
,
Foster S
,
Vartanian T
,
Perumal JS
. 2018.
Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.
.
Mult Scler. 24(4):540-542.
Kocsik AS
,
Klein DE
,
Liedke M
,
Kaunzner UW
,
Nealon NM
,
Gauthier SA
,
Vartanian T
,
Perumal JS
. 2018.
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.
.
J Neurol. 265(5):1226-1229.
Fox RJ
,
Coffey CS
,
Conwit R
,
Cudkowicz ME
,
Gleason T
,
Goodman A
,
Klawiter EC
,
Matsuda K
,
McGovern M
,
Naismith RT
et al.
. 2018.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
.
N Engl J Med. 379(9):846-855.
Ranganathan U
,
Kaunzner U
,
Foster S
,
Vartanian T
,
Perumal JS
. 2018.
Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.
.
Mult Scler. 24(4):553-554.
2017
Al-Kawaz M
,
Monohan E
,
Morris E
,
Perumal JS
,
Nealon N
,
Vartanian T
,
Gauthier SA
. 2017.
Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.
.
J Neuroimaging. 27(3):333-338.
2016
Kaunzner UW
,
Kumar G
,
Askin G
,
Gauthier SA
,
Nealon NN
,
Vartanian T
,
Perumal JS
. 2016.
A study of patients with aggressive multiple sclerosis at disease onset.
.
Neuropsychiatr Dis Treat. 12:1907-12.
2015
Babij R
,
Perumal JS
. 2015.
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
.
Neuropsychiatr Dis Treat. 11:1221-9.
Perumal JS
,
Kister I
,
Howard J
,
Herbert J
. 2015.
Disease exacerbation after rituximab induction in neuromyelitis optica.
.
Neurol Neuroimmunol Neuroinflamm. 2(1):e61.
2013
Vargas WS
,
Perumal JS
. 2013.
Fingolimod and cardiac risk: latest findings and clinical implications.
.
Ther Adv Drug Saf. 4(3):119-24.
Reardon J
,
Perumal JS
. 2013.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
.
Drug Des Devel Ther. 7:1187-93.
2012
Perumal JS
,
Foo F
,
Cook P
,
Khan O
. 2012.
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.
.
Mult Scler. 18(8):1197-9.